Allscripts (MDRX) Higher as First-Round Bidding Complete
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
New Allscripts (MDRX) CFO Won't Affect M&A Potential - Analyst
October 15, 2012 2:14 PM EDTAllscripts (Nasdaq: MDRX) stock is lower Monday after announcing Richard J. Poulton will become its new CFO earlier.... More
Allscripts (MDRX) said to be exploring possible sale to private equity
September 28, 2012 12:44 PM EDTAllscripts-Misys Healthcare Solution (NASDAQ:... More
Allscripts (MDRX) Misses Q1 EPS by 12c; Lowers FY12 Outlook; 4 Directors, CFO to Leave
April 26, 2012 4:19 PM EDTAllscripts (NASDAQ: MDRX) reported Q1 EPS of $0.12, $0.12 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $364.7 million versus the consensus estimate of $387.82 million.
Allscripts sees FY2012 EPS of $0.74-$0.80, versus prior guidance of... More
